This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pushing It to the Maximus: Under the Radar

RESTON, Va. ( TheStreet) -- Small-cap stock-market indices are rife with companies in poor financial shape with dim prospects.

That's especially true in business services and consulting, which requires highly skilled -- and paid -- employees who compete against formidable competitors such as IBM (IBM - Get Report) and Accenture (ACN - Get Report).

Weak companies like Zanett (ZANE), The Hackett Group (HCKT - Get Report) and TMNG Global (TMNG) are omnipresent, but small-cap investors have better options. One such company is Reston, Va.-based Maximus (MMS - Get Report), which provides operations program management and consulting services to government groups.

Maximus derives much of its revenue from operations management on Medicare and Medicaid programs, which would grow with the passage of health-care reform proposed by President Barack Obama. A bill is working its way through the U.S. House of Representatives.

Granted, many of the initiatives in the health-care legislation wouldn't be rolled out until 2013 or later, but in the ramp-up stage, Maximus' workflow would increase massively. Even without such a shot in the arm, the company's fundamentals alone suggest it's a sound investment.

Maximus' stock increased almost 70% over the past year, in line with the Russell 2000 Index of small-company stocks. This year, Maximus has risen 22%, double that of the index. Maximus was first featured as an Under the Radar pick on Dec. 31, before the company released year-end results that were better than analysts had expected.

There may be more gains ahead. Maximus' return on equity is more than 20%, and its price-to-earnings ratio is 16.2, less than the peer-group average of 22.2.

The company has no long-term debt, with a cash balance of $131 million, giving it a lot of flexibility. Maximus could take on a modest amount of debt to fuel growth without increasing risk. A current ratio of nearly 2.2 illustrates the company's financial flexibility. Above 1 is considered strong.

A dividend yield of about 0.8% and a share-buyback program provided investors with some cash. Maximus' healthy financial situation should make expansion in the face of new regulations easy.

For Maximus to fully realize the benefits from the expansion of Medicare and Medicaid, investors will need to hold the stock for quite some time. As can be seen by its 2010 performance, however, this company is primed to cash in on the aging population.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ZANE $0.07 0.00%
TMNG $3.33 -4.67%
ACN $107.46 0.00%
HCKT $19.03 0.00%
IBM $138.46 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs